Success Metrics

Completion Rate
0%(0/2)
Active Trials
2(40%)
Terminated
2(40%)

Phase Distribution

Ph phase_1
1
20%
Ph not_applicable
1
20%
Ph phase_2
3
60%

Phase Distribution

1

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(2)
Other(1)

Detailed Status

Terminated2
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
N/A1 (20.0%)

Trials by Status

recruiting120%
terminated240%
unknown120%
active_not_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingphase_1

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

NCT03028311
recruitingphase_2

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

NCT06860815
unknownphase_2

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

NCT00436267
terminatednot_applicable

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

NCT00469963
terminatedphase_2

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

NCT00466856

Clinical Trials (5)

Showing 5 of 5 trials
NCT03028311Phase 1

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Active Not Recruiting
NCT06860815Phase 2

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Recruiting
NCT00436267Phase 2

Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery

Unknown
NCT00469963Not Applicable

Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Terminated
NCT00466856Phase 2

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Terminated

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5